Ceragenix Pharmaceuticals, Inc. CGXP Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Ceragenix Pharmaceuticals, Inc. CGXP Company Overview 

Stock Message Board http://investorshangout.com/search?q=CGXP&...mp;yt1=Go!

Ceragenix Pharmaceuticals, Inc. CGXP Current Price and Quotes
Last Price 0.0013
Previous Close 0.0013 Open N/A
Daily Range N/A - N/A 52wk Range 0.0065 - 0.001
Volume 0 Dividend N/A
Average Vol (3m) 6,006 Yield N/A
Ceragenix Pharmaceuticals, Inc. CGXP
Company Information

1444 Wazee Street
Suite 210
Denver, CO 80202

Phone: (720) 946-6440

Ceragenix Pharmaceuticals, Inc. CGXP
Ceragenix Pharmaceuticals, Inc. CGXP
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Unaudited
Latest Report Dec 31, 2009 10-K
CIK 0001180743
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Steven S. Porter CEO
Jeffrey Sperber CFO
Company Directors

Not Available
Company Notes

Formerly=OnSource Corp. until 6-05
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Ceragenix Pharmaceuticals, Inc. CGXP
CGXP Security Details

Share Structure

Market Value1 $23,008 a/o Sep 13, 2013
Shares Outstanding 17,698,293 a/o Aug 18, 2008
Float Not Available
Authorized Shares Not Available
Par Value  0.0001
Shareholders

Shareholders of Record 800 a/o Mar 31, 2008
Short Selling Data

Short Interest 0 (-100%)
Jun 30, 2011
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

Ceragenix Pharmaceuticals, Inc. CGXP Recent News

Ceragenix Pharmaceuticals, Inc. CGXP Financials
CGXP


CGXP Ceragenix Pharmaceuticals, Inc. Research DD Guide

CGXP Ceragenix Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=CGXP&...mp;yt0=Go!
CGXP Ceragenix Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/CGXP/quote
CGXP Ceragenix Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/CGXP/chart
CGXP Ceragenix Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/CGXP/company-info
CGXP Ceragenix Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/CGXP/news
CGXP Ceragenix Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/CGXP/financials
CGXP Ceragenix Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/CGXP/filings
CGXP Ceragenix Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/CGXP/short-sales
CGXP Ceragenix Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/CGXP/insider-transactions
CGXP Ceragenix Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/CGXP/research
CGXP Ceragenix Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=CGXP+Historical+Prices
CGXP Ceragenix Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=CGXP+Basic+Chart
CGXP Ceragenix Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CGXP+Basic+Tech.+Analysis
CGXP Ceragenix Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=CGXP+Headlines
CGXP Ceragenix Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=CGXP+Press+Releases
CGXP Ceragenix Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=CGXP+Profile
CGXP Ceragenix Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=CGXP+Key+Statistics
CGXP Ceragenix Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=CGXP+Industry
CGXP Ceragenix Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=CGXP+Major+Holders
CGXP Ceragenix Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=CGXP+Insider+Transactions
CGXP Ceragenix Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=CGXP+Insider+Roster
CGXP Ceragenix Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=CGXP+Cash+Flow&annual
CGXP Ceragenix Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/CGXP:US
CGXP Ceragenix Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/CGXP
CGXP Ceragenix Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=CGXP
CGXP Ceragenix Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/CGXP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Greenberg Traurig Nabs Major Award for Sukuk Deal

Updated Category News Views 4

Legal brands winning awards might seem like just another day in the office, but when a firm like Greenberg Traurig snags the Impact Deal of the Year at the IFLR Middle East Awards, it deserves more than just a shrug. We're talking about a serious feather in the cap for their Capital Markets team, who played a key role in launching Binghatti's hefty USD 1.5 billion Sukuk...

Continue Reading
Chianti Classico Showcases 2027 Vintages in Florence

Updated Category News Views 4

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

Continue Reading
ODL’s Impact Door System Wins 2026 Editors' Pick

Updated Category News Views 4

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Continue Reading
Duke Energy Braces for Isaias: Key Prep Steps Ahead

Updated Category News Views 6

Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...

Continue Reading
2026 Leica Oskar Barnack Awards Spotlight Global Talent

Updated Category News Views 7

Winners Redefine Photography's Boundaries in 2026 Photographers are like modern-day storytellers, freezing moments in time and weaving visual narratives that provoke thought—or at least that's what the folks behind the Leica Oskar Barnack Award (LOBA) seem to believe. This year's ceremony upped the ante, not just handing out glittering prizes and shiny cameras, but...

Continue Reading
Bill Evans Enhances Gateway's Wealth Management Expertise

Updated Category News Views 5

Welcome Aboard, Bill Evans Some days the financial world throws a gem your way, something worth more than a rat-race racehorse in a shattered stock rally. Meet Bill Evans, a seasoned professional stepping into the vibrant arena of Gateway Financial Partners. He’s put in 29 years around the investment block, and now he’s parking himself in Glastonbury, Connecticut, set...

Continue Reading
TKO's Bold $2B All-Cash Move for SVC's Hotels

Updated Category News Views 5

TKO's Big, Bold Bid: What Does it Mean? In the crazy world of high-stakes hospitality investments, there are moments that turn heads. TKO's $2 billion all-cash offer to snag Service Properties Trust's prized hotel portfolio is exactly one of those shake-ups. Let's not sugarcoat it; this is a bold move to the big leagues, and it's not without its quirks. A Cash-Infused...

Continue Reading
Choate's: 68 Years of Community and Family Values

Updated Category News Views 4

Beyond Business: A Legacy of Giving Step into the world of Choate's, a renowned name in the Memphis area not just for its services in air conditioning, heating, plumbing, and electrical needs, but for its unwavering dedication to community service. For 68 years, this family-owned business has made its mark on the heart of Tennessee, spanning three generations and staying...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
BETR Faces Securities Fraud Actions Post-Misleading Statements

Updated Category News Views 3

Unpacking the Legal Drama Around BETR The tale of Better Home & Finance Holding Company (BETR) is like a roadside crash you can't help but stare at. We're talking big, ugly losses and a chance for investors who got roughed up to throw some punches back with a securities fraud class action. The legal honchos at Howard G. Smith's law office are rallying the troops. If...

Continue Reading

Top 5 Most Recently Viewed Articles

Disguise Enhances Partnership with Aniplex for Demon Slayer Costumes

Updated Category News Views 141

Disguise Expands Licensing Agreement with Aniplex Disguise, Inc., the innovative costume division of renowned toy manufacturer JAKKS Pacific, Inc. (NASDAQ: JAKK), is thrilled to announce an expanded licensing agreement with Aniplex Inc. This collaboration centers around the immensely popular anime and manga franchise, Demon Slayer: Kimetsu no Yaiba. New Licensing Terms...

Continue Reading
Jay Atlas: A Decade of Activism and Hope on the Road

Updated Category News Views 479

Reflecting on a Decade of Activism Where do you feel you truly thrive? This thought-provoking question from a therapist leads Joshua “Jay” Atlas to ponder his life and the impact he’s made. As the Operation Manager for Bio-One Philly and a committed community advocate, he finds fulfillment in helping others, even while navigating his own challenges. Discovering...

Continue Reading
Investors Urged to Join Petco Class Action Against Securities Fraud

Updated Category News Views 168

Investors Encouraged to Take Action Against Petco's Securities Fraud Faruqi & Faruqi, LLP, a respected name in securities law, is currently reaching out to all investors who may have experienced monetary losses exceeding $100,000 with Petco Health and Wellness Company, Inc. (NASDAQ: WOOF). This is a significant opportunity for affected individuals to engage and seek...

Continue Reading
New Leadership Changes in KN Energies' Nomination Committee

Updated Category News Views 166

New Leadership Changes in KN Energies' Nomination Committee AB „KN Energies“ has recently made significant changes to its Remuneration and Nomination Committee, reflecting their commitment to strong governance and leadership. The Supervisory Council of the company has appointed a new member who will play a crucial role in guiding the company's executive decisions....

Continue Reading
Skye Bioscience Welcomes New Chairman Paul Grayson for Growth

Updated Category News Views 233

Skye Bioscience Welcomes New Leadership Skye Bioscience, Inc. (NASDAQ: SKYE), a forefront clinical-stage biopharmaceutical firm, has recently appointed Paul Grayson as the new Chairman of the Board. This significant change is aimed at reinforcing governance structures and enhancing oversight capabilities as the company navigates through its developmental phases. Paul...

Continue Reading